FEMOSTON CONTI 1/5 10 S

About

Femoston Conti 1/5 is a continuous combined hormone replacement therapy (HRT) specifically formulated for postmenopausal women with an intact uterus. It contains two active ingredients: estradiol, an estrogen, and dydrogesterone, a progestogen. Estradiol replaces the estrogen that the body no longer produces after menopause, effectively alleviating common menopausal symptoms such as hot flashes, night sweats, vaginal dryness, and mood disturbances. Dydrogesterone is included to protect the uterine lining from the proliferative effects of estrogen, thereby reducing the risk of endometrial hyperplasia and cancer, which can occur when estrogen is given alone to women with a uterus.

This continuous combined regimen means that both hormones are taken daily without a break, resulting in no monthly bleeding for most women. It is particularly suitable for women who are at least 12 months post-menopause. Femoston Conti 1/5 aims to improve the quality of life for women experiencing bothersome menopausal symptoms, while also offering potential benefits for bone health by helping to prevent osteoporosis. Regular medical evaluation is essential to assess the ongoing need for HRT and to monitor for any potential risks or side effects.

Uses

• Relief of menopausal symptoms.
• Prevention of postmenopausal osteoporosis.
• Hormone replacement therapy for women with an intact uterus.
• Management of vasomotor symptoms (hot flashes, night sweats).

Directions For Use

Take one tablet daily, at approximately the same time each day, without interruption.

Benefits

• Effectively relieves menopausal symptoms.
• Reduces hot flashes and night sweats.
• Prevents bone loss and osteoporosis.
• Improves vaginal dryness and discomfort.
• Enhances mood and sleep quality.
• Provides continuous hormone support without monthly bleeding.

Side Effects

• Breast tenderness/pain
• Headache
• Nausea
• Abdominal pain
• Vaginal bleeding/spotting
• Weight changes
• Mood changes
• Dizziness
• Bloating
• Leg cramps
• Increased risk of blood clots (rare)
• Increased risk of certain cancers (rare)

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake may affect liver metabolism of hormones.
• Pregnancy - Contraindicated during pregnancy; it is not a contraceptive and should not be used if pregnant or planning pregnancy.
• Breastfeeding - Not recommended during breastfeeding as hormones may pass into breast milk and affect the infant.
• Liver - Contraindicated in patients with severe liver disease or a history of liver tumors. Use with caution in mild to moderate impairment.
• Kidney - Use with caution in patients with kidney impairment, as fluid retention may occur.
• Lung - Use with caution in patients with a history of venous thromboembolism or pulmonary embolism, as HRT can increase risk.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.